Date: October 10, 2023
The Nordic region continues to be a beacon of innovation with private stage biotechs and startups continually raising capital, but in 2023 how are some of Europe’s leading investors viewing the field? This panel will discuss how investors are allocating their capital, hot trends to look out for, and how best private stage biotechs can utilise their capital efficiently as we head into 2024 and beyond.
- How are investors viewing the field of the Nordic life sciences as an attractive region to invest in?
- What has got some of the leading investors in the space excited this year, and what are they going to be on the lookout in 2024?
- What have we learned in terms of navigating the private markets in 2023 and how can biotechs be best prepared for the future?